2901 related articles for article (PubMed ID: 7654000)
21. Neoplastic transformation of human cells in vitro.
Rhim JS
Crit Rev Oncog; 1993; 4(3):313-35. PubMed ID: 8485202
[TBL] [Abstract][Full Text] [Related]
22. The evidence for human tumor suppressor genes.
Stanbridge EJ
Princess Takamatsu Symp; 1989; 20():3-13. PubMed ID: 2577336
[TBL] [Abstract][Full Text] [Related]
23. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
24. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.
Takahashi C; Akiyama N; Matsuzaki T; Takai S; Kitayama H; Noda M
Oncogene; 1996 May; 12(10):2137-46. PubMed ID: 8668339
[TBL] [Abstract][Full Text] [Related]
26. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
Bowden GT; Schneider B; Domann R; Kulesz-Martin M
Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
[TBL] [Abstract][Full Text] [Related]
27. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation.
Jiang K; Delarue FL; Sebti SM
Oncogene; 2004 Feb; 23(5):1136-45. PubMed ID: 14647415
[TBL] [Abstract][Full Text] [Related]
28. Ras-responsive genes and tumor metastasis.
Chambers AF; Tuck AB
Crit Rev Oncog; 1993; 4(2):95-114. PubMed ID: 8420573
[TBL] [Abstract][Full Text] [Related]
29. [Activated oncogenes in human tumors].
Noguchi T; Adelaide J; Marics I; Raybaud F; de Lapeyrière O; Birnbaum D
Bull Cancer; 1987; 74(6):607-21. PubMed ID: 3325106
[TBL] [Abstract][Full Text] [Related]
30. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
[TBL] [Abstract][Full Text] [Related]
31. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of c-erbB-2 and c-myc but not c-ras, in canine melanoma cell lines, is associated with metastatic potential in nude mice.
Ahern TE; Bird RC; Bird AE; Wolfe LG
Anticancer Res; 1993; 13(5A):1365-71. PubMed ID: 8239507
[TBL] [Abstract][Full Text] [Related]
33. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
Voskas D; Mader R; Lee J; Hurta RA
Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
[TBL] [Abstract][Full Text] [Related]
34. The properties of p53 proteins selected for the loss of suppression of transformation.
Olson DC; Levine AJ
Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
[TBL] [Abstract][Full Text] [Related]
35. Transforming activity of the c-Ha-ras oncogene having two point mutations in codons 12 and 61.
Sekiya T; Prassolov VS; Fushimi M; Nishimura S
Jpn J Cancer Res; 1985 Sep; 76(9):851-5. PubMed ID: 3932284
[TBL] [Abstract][Full Text] [Related]
36. Tumor-suppressive function of mutated gelsolin in ras-transformed cells.
Müllauer L; Fujita H; Ishizaki A; Kuzumaki N
Oncogene; 1993 Sep; 8(9):2531-6. PubMed ID: 8395682
[TBL] [Abstract][Full Text] [Related]
37. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
[TBL] [Abstract][Full Text] [Related]
38. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
[TBL] [Abstract][Full Text] [Related]
39. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
40. Cell cycle gene regulation in reversibly differentiated new human hepatoma cell lines.
Glaise D; Ilyin GP; Loyer P; Cariou S; Bilodeau M; Lucas J; Puisieux A; Ozturk M; Guguen-Guillouzo C
Cell Growth Differ; 1998 Feb; 9(2):165-76. PubMed ID: 9486853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
